Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT05074953Completed

Post-COVID-19 Monitoring in Routine Health Insurance Data

Role: collaborator

NCT05524792Completed

Incidence of Diabetes After a COVID-19 Infection

Role: collaborator

NCT04698876Not ApplicableCompleted

Self Tonometry and Transfer of Glaucoma Patients' Data for Improving the Supply Situation

Role: collaborator

NCT05606198Completed

Post-COVID-19 Monitoring in Routine Health Insurance Data With Focus on Autoimmune Diseases (POINTED-AD)

Role: collaborator

NCT05251298Not ApplicableUnknown

"Parkinson AKTIV - Non-pharmacological Treatments in an Innovative Parkinson's Network"

Role: collaborator

NCT03885102Not ApplicableCompleted

Dialysis Training Therapy: The DiaTT Trial

Role: collaborator

NCT05479292Completed

Allocating Resources for Cancer Care in Times of the Sars-CoV-2 Outbreak. Health Care Research

Role: collaborator

All 7 trials loaded